c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Systemic injections of kainic acid (KA) cause epileptic seizures with delayed neuronal damage in the limbic system, particularly in the hippocampus. KA excitotoxicity activates complex signal transduction events that trigger apoptotic cell death. The c‐Jun N‐terminal kinase (JNK) pathway plays an important role in cell death, and the peptide D‐JNKI1, a competitive JNK inhibitor, is a potent neuroprotective agent. To analyse the role of JNK and the effects of D‐JNKI1 administration on excitotoxic neuronal death, we induced epileptic seizures by intraperitoneal (i.p.) injection of KA in adult male Sprague–Dawley rats; a group of rats received i.p. D‐JNKI1 2 h after KA. KA caused massive cell death in the hippocampus: in Nissl‐stained sections, stereological counts showed a significant decrease in neuronal density in all CA fields, both at 1 and 5 days after seizures, which was partially prevented by D‐JNKI1 treatment. These results were confirmed by counts of degenerating neurons in CA3 in FluoroJade B‐stained sections. Seizure activity also induced marked gliosis as observed with glial fibrillary acidic protein (GFAP) immunohistochemistry. We also analysed c‐Jun activation as a target of JNK and central transcriptional effector in the adult rat brain following KA injection. Phospho‐c‐Jun immunoreactivity was absent in the hippocampus of untreated animals, whereas strong nuclear neuronal labeling could be observed, starting from 3 h after KA administration, in microtubule‐associated protein‐2‐positive neurons but not in GFAP‐positive astrocytes. D‐JNKI1 treatment also reduced the positivity for phospho‐c‐Jun in the hippocampus, thus confirming the specificity of the peptide in blocking JNK. Therefore, JNK is a promising target for blocking seizure‐induced cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 1×
“One chemical inhibitor, SP600125, acts as a reversible ATP-competitive JNK inhibitor (Bennett et al., 2001).”
BackgroundA peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658
Self-citationCell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571 · cited 2×
“A completely different inhibitor, the selective cell-permeable peptide inhibitor D-JNKI1, prevents the protein–protein interaction between JNK and its targets, without interfering with JNK’s ATP binding (Bonny et al., 2001).”
BackgroundSelf-citationAngiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Rigau, V., Morin, M., Rousset, M.-C., de Bock, F., Lebrun, A., Coubes, P., Picot, M.-C., Baldy-Moulinier, M., Bockaert, J., Crespel, A., et al. (2007) · Brain · doi:10.1093/brain/awm118 · Cited by 429
Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures
Lehtimäki, K. A., Peltola, J., Koskikallio, E., Keränen, T., & Honkaniemi, J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00654-x · Cited by 163
Cited by
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
Zeke, A., Misheva, M., Reményi, A., & Bogoyevitch, M. A. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-14 · Cited by 523
Nuclear and cytosolic JNK signalling in neurons
Coffey, E. T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3729 · Cited by 338
Epilepsy and Inflammation in the Brain: Overview and Pathophysiology
Vezzani, A. (2014) · Epilepsy Currents · doi:10.5698/1535-7511-14.s2.3 · Cited by 208
The role of dopamine signaling in epileptogenesis
Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199
“Jun phosphorylation (mediated by the c-Jun N-terminal kinase, JNK) activates Jun transcriptional activity and triggers apoptotic neuronal cell death after seizures (Schauwecker, 2000; Bozzi et al., 2000; Spigolon et al., 2010).”
Gourmaud, S., Shou, H., Irwin, D. J., Sansalone, K., Jacobs, L. M., Lucas, T. H., Marsh, E. D., Davis, K. A., Jensen, F. E., & Talos, D. M. (2020) · Brain · doi:10.1093/brain/awz381 · Cited by 155
Metadata
- Authors
- Spigolon, G., Veronesi, C., Bonny, C., & Vercelli, A.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2010-04
- Volume
- 31
- Issue
- 7
- Pages
- 1261-1272
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2031855726
- Cited by
- 62
- References
- 6
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus. https://app.cochat.ai/papers/10.1111/j.1460-9568.2010.07158.x
- The paper
- Spigolon, G., Veronesi, C., Bonny, C., & Vercelli, A. (2010). c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2010.07158.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.